lobbying_activities: 1368873
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1368873 | 7c47ccf1-aeb3-4e9b-a9e9-2895b59a6214 | Q1 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2013 | first_quarter | TAX | *AACC wrote letters endorsing H.R.523, the Protect Medical Innovation Act, and S. 232, the Medical Device Access and Innovation Protection Act, which would repeal the 2.3 percent medical device excise tax imposed on medical device manufacturers as part of the Affordable Care Act (Section 9009). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-04-04T13:40:41.693000-04:00 |